Anti-TCEAL7 antibodies are used in the immunodetection of the protein transcription elongation factor A like 7. In humans, the canonical protein has a reported length of 100 amino acid residues and a mass of 12.3 kDa. Its subcellular localization is in the nucleus. It is reported to be highly expressed in normal and fetal brain tissues, and weakly expressed in uterus and ovary. A member of the TFS-II protein family, TCEAL7 is reported to play a role in the negative regulation of NF-kappa-B signaling at the basal level by modulating transcriptional activity of NF-kappa-B on its target gene promoters. Synonyms for this target antigen include TCEA-like protein 7, transcription elongation factor A (SII)-like 7, transcription elongation factor S-II protein-like 7, and transcription elongation factor A protein-like 7. TCEAL7 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species. A number of TCEAL7 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.